
Pete Sessions Periodic Transaction Report
Filed Aug 17, 2023 · House Clerk · 3 transactions
U.S. Representative · R · TX-17 · All trades by Pete Sessions
On August 17, 2023, Rep. Pete Sessions (R-TX-17) filed a periodic transaction report with the House Clerk disclosing 3 transactions (2 purchases, 1 sale) dated Jul 28, 2023 through Aug 15, 2023.
The filing covers 2 tickers, including $ARCC, $KD.
Reported amount ranges sum to $15K–$50K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 20 days.
3 transactions were reported under a spouse, dependent child, or joint account rather than the member directly.
Source document: House Clerk filing 20023399
Sample · the intelligence layer
Pete Sessions · Bought $ARCC · Aug 15 · $155–$155
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Pete Sessions
Get an email the moment Pete Sessions files the next one. Free, no card, no spam.
Tickers in this filing
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Jul 28, 2023 | KDKDKyndryl Holdings, Inc. | Kyndryl Holdings, Inc. (KD) | sell | Spouse | $163–$163 | 20d |
| Jul 28, 2023 | — | US Treasury BILL 01/11/2024 5.472% | buy | Spouse | $15K–$50K | 20d |
| Aug 15, 2023 | ARCCARCCAres Capital Corporation - Closed End Fund | Ares Capital Corporation - Closed End Fund (ARCC) | buy | Spouse | $155–$155 | 2d |
Other recent filings by Pete Sessions
- PTR filed Jul 24, 20261 trade · ARCC
- PTR filed Mar 9, 20261 trade · VZ
- PTR filed Nov 7, 20251 trade
- PTR filed Oct 22, 20251 trade
- PTR filed Sep 15, 20251 trade
- PTR filed Jun 21, 20252 trades · DHR, JNJ
← All congressional filings, newest first
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →